Vanita Noronha, Atul Budukh, Pankaj Chaturvedi, Anne Srikanth et al.
rearrangements are noted in 5-7%. Therapies are similar to global standards, although access to newer modalities and molecules is a challenge. Collaborative research, political will with various policy changes and patient advocacy are urgently needed.
Vanita Noronha, Vandana Mahajan, Ravi Prakash, Sanjeev Sharma et al.
Globally, patient advocacy and support groups have helped advance science and patient care, however, this is an unmet need in India. In 2017, Rise To Survive, a support group for patients with ALK-positive lung cancer, was created in India.1https://risetosurvivecancer.com/2018/09/05/alk-positive-ind...
Prabhat Singh Malik, Rajendra Baral, Bhuvan Chugh, Emad Dawoud et al.
ABSTRACT The Excellence in Oncology Care (EIOC) 2023 Congress, held in Dubai, took place both in person and online. This annual event brought together oncologists from across the Middle East and the Indian subcontinent. A panel of 17 regional experts worked together to develop the first region-speci...
Rajiv Kumar, Vijay Patil, Yasmin Abdul Rashid, Alfredo Addeo et al.
ABSTRACT The Excellence in Oncology Care (EIOC) 2023 Congress, held in Dubai as a hybrid event, brought together oncologists from the Middle East and the Indian subcontinent. Two panels, comprising 33 experts, developed the first region-specific consensus guidelines to address critical issues in non...
Vanita Noronha, Aref Chehal, Abhijith Rajaram Rao, Joyita Banerjee et al.
ABSTRACT The Excellence in Oncology Care (EIOC) 2023 Congress, held in Dubai, convened oncologists from the Middle East and the Indian subcontinent, both in person and online. The goal of this annual event was to develop the first region-specific consensus guidelines for geriatric evaluation in non-...